CONDENSED STATEMENTS OF OPERATIONS (UNAUDITED) - USD ($)	3 Months Ended
	Dec. 31, 2023	Dec. 31, 2022
Operating expenses:
Research and development	$ 4,352,509	$ 5,392,546
General and administrative	2,133,378	2,258,003
Total operating expenses	6,485,887	7,650,549
Operating loss	(6,485,887)	(7,650,549)
Interest expense, net	(197,696)	(152,789)
Other expense	(25,941)	(50,171)
Net loss	(6,709,524)	(7,853,509)
Modification of warrants	0	(171,552)
Net loss available to common shareholders	$ (6,709,524)	$ (8,025,061)
Net loss per common share - basic and diluted	$ (0.14)	$ (0.18)
Weighted average common shares outstanding - basic and diluted	48,470,600	43,440,387